STXS
Stereotaxis, Inc.Company Information
- Company Name
- Stereotaxis, Inc.
- CIK
- CIK0001289340
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- STXS: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3845
- SIC Description
- Electromedical & Electrotherapeutic Apparatus
- Ticker
- STXS
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-11-17
- Last sale
- —
- Shares purchased (TTM)
- 49,489
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 40,178,932
- Shares outstanding
- 100,031,760
- Ownership
- 40.17%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- -0.71%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 10 | 15 | 13 | 11 | 7 | 11 | 12 | 11 | 15 | 18 | 20 | 22 | ||||||
| Restricted Cash Current | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Accounts Receivable Net Current | 8 | 5 | 6 | 5 | 4 | 4 | 4 | 8 | 3 | 4 | 4 | 5 | ||||||
| Inventory Net | 13 | 10 | 10 | 10 | 10 | 10 | 8 | 9 | 9 | 8 | 8 | 7 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 38 | 36 | 34 | 27 | 22 | 26 | 26 | 29 | 28 | 31 | 33 | 36 | ||||||
| Property Plant And Equipment Net | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | ||||||
| Restricted Cash Noncurrent | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | 7 | 8 | - | - | - | - | ||||||
| Goodwill | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | - | - | - | - | ||||||
| Finite Lived Intangible Assets Net | 6 | 6 | 6 | 7 | 7 | 7 | 7 | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 1 | 5 | 5 | 5 | 5 | ||||||
| Prepaid Expense And Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 56 | 54 | 52 | 46 | 41 | 46 | 47 | 51 | 36 | 39 | 42 | 45 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 7 | 5 | 5 | 5 | 7 | 7 | 6 | 6 | 4 | 3 | 3 | 3 | ||||||
| Accrued Liabilities Current | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Contract With Customer Liability Current | 6 | 7 | 6 | 8 | 6 | 8 | 7 | 5 | 5 | 6 | 7 | 6 | ||||||
| Asset Acquisition Contingent Consideration Liability Current | - | - | - | - | 6 | 6 | 6 | 5 | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Current | 6 | 5 | 5 | 6 | - | - | 6 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 27 | 23 | 22 | 20 | 21 | 24 | 22 | 21 | 12 | 13 | 13 | 13 | ||||||
| Contract With Customer Liability Noncurrent | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Asset Acquisition Contingent Consideration Liability Noncurrent | - | - | - | - | 6 | 6 | 6 | 6 | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 5 | 5 | 5 | 7 | - | - | 6 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | ||||||
| Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 38 | 34 | 34 | 34 | 34 | 38 | 35 | 35 | 19 | 19 | 20 | 20 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | - | - | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 606 | 604 | 597 | 584 | 573 | 571 | 568 | 565 | 559 | 557 | 554 | 551 | ||||||
| Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -594 | -589 | -583 | -578 | -571 | -568 | -562 | -554 | -548 | -542 | -538 | -533 | ||||||
| Stockholders Equity | 12 | 14 | 13 | 6 | 1 | 3 | 6 | 11 | 11 | 15 | 16 | 19 | ||||||
| Liabilities And Stockholders Equity | 56 | 54 | 52 | 46 | 41 | 46 | 47 | 51 | 36 | 39 | 42 | 45 | ||||||
| Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Temporary Equity Par Or Stated Value Per Share | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Par Or Stated Value Per Share | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | ||||||
| Temporary Equity Shares Authorized | - | - | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | - | 10 | 10 | ||||||
| Temporary Equity Shares Outstanding | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 98 | 97 | 95 | 91 | 86 | 86 | 85 | 85 | 83 | 82 | 81 | 81 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialStereotaxis, Inc. (STXS) — SEC Financial Statements & Analysis
Stereotaxis, Inc. (STXS) is a electromedical & electrotherapeutic apparatus company, incorporated in DE. Stereotaxis, Inc. trades on NYSE as: STXS. Stereotaxis, Inc. (STXS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, Stereotaxis, Inc. carries a market cap of $172.05M, a P/E ratio of -7.82x, a P/B ratio of 14.05x, a P/S ratio of 5.72x, an enterprise value of $161.56M, and an EV/EBITDA multiple of -7.31x. On profitability, it posts a gross margin of 55.57%, an operating margin of -75.68%, a net margin of -73.18%, a Return on Equity (ROE) of -321.26%, and a Return on Assets (ROA) of -45.49%. Per share, it reports EPS of $-0.22, diluted EPS of $-0.22, free cash flow per share of $-0.15, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -5.46% year-over-year, net income growth of -8.26% year-over-year, and EPS growth of -19.34% year-over-year. On the balance sheet, it maintains a current ratio of 1.42x, a quick ratio of 0.91x, working capital of $11.19M, a debt-to-equity ratio of 3.11x, a debt ratio of 0.69, an interest coverage ratio of -52.43x, free cash flow of $-15.50M (TTM), and net debt of $-10.49M. Figures sourced from SEC EDGAR.
- Market Cap
- $172.05M
- P/E TTM
- -7.82x
- EPS TTM
- $-0.22
- P/B TTM
- 14.05x
- ROE TTM
- -321.26%
- ROA TTM
- -45.49%
- Debt To Equity
- 3.11x
- Free Cash Flow TTM
- $-15.50M
- Net Revenue TTM Growth 1Y
- -5.46%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Stereotaxis, Inc. in?
Stereotaxis, Inc. (STXS) operates in the Electromedical & Electrotherapeutic Apparatus industry.
What exchange does STXS trade on?
Stereotaxis, Inc. (STXS) trades on the NYSE.
Where is Stereotaxis, Inc. incorporated?
Stereotaxis, Inc. is incorporated in DE.
When was Stereotaxis, Inc. (STXS)'s most recent SEC filing?
Stereotaxis, Inc. (STXS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is STXS's market cap?
Stereotaxis, Inc. (STXS) has a market capitalization of $172.05M as of 2026-06-30.
What is STXS's EPS (earnings per share)?
Stereotaxis, Inc. (STXS)'s trailing twelve month EPS is $-0.22 as of 2026-06-30.
What is STXS's ROE (return on equity)?
Stereotaxis, Inc. (STXS)'s trailing twelve month Return on Equity (ROE) is -321.26% as of 2026-06-30.
What is STXS's ROA (return on assets)?
Stereotaxis, Inc. (STXS)'s trailing twelve month Return on Assets (ROA) is -45.49% as of 2026-06-30.
What is STXS's EV/EBITDA?
Stereotaxis, Inc. (STXS)'s trailing twelve month EV/EBITDA is -7.31x as of 2026-06-30.